Armstrong Shaw Associates Inc. CT decreased its position in Dow Chemical Company (The) (NYSE:DOW) by 36.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 179,646 shares of the basic materials company’s stock after selling 105,211 shares during the period. Dow Chemical Company (The) comprises about 4.3% of Armstrong Shaw Associates Inc. CT’s investment portfolio, making the stock its 5th largest position. Armstrong Shaw Associates Inc. CT’s holdings in Dow Chemical Company (The) were worth $11,330,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of DOW. Macquarie Group Ltd. raised its position in Dow Chemical Company (The) by 112.4% in the fourth quarter. Macquarie Group Ltd. now owns 341,482 shares of the basic materials company’s stock valued at $19,540,000 after buying an additional 180,697 shares during the last quarter. Park National Corp OH raised its position in Dow Chemical Company (The) by 0.9% in the first quarter. Park National Corp OH now owns 52,941 shares of the basic materials company’s stock valued at $3,364,000 after buying an additional 489 shares during the last quarter. First Financial Bank N.A. Trust Division raised its position in Dow Chemical Company (The) by 28.9% in the first quarter. First Financial Bank N.A. Trust Division now owns 5,104 shares of the basic materials company’s stock valued at $324,000 after buying an additional 1,144 shares during the last quarter. Foundry Partners LLC raised its position in Dow Chemical Company (The) by 18.5% in the first quarter. Foundry Partners LLC now owns 265,650 shares of the basic materials company’s stock valued at $16,879,000 after buying an additional 41,525 shares during the last quarter. Finally, Franklin Street Advisors Inc. NC raised its position in Dow Chemical Company (The) by 15.9% in the first quarter. Franklin Street Advisors Inc. NC now owns 11,236 shares of the basic materials company’s stock valued at $714,000 after buying an additional 1,540 shares during the last quarter. Hedge funds and other institutional investors own 68.79% of the company’s stock.

Dow Chemical Company (NYSE:DOW) traded up 0.24% during midday trading on Friday, hitting $63.26. 4,990,267 shares of the stock were exchanged. The firm has a 50 day moving average of $64.62 and a 200-day moving average of $63.06. The stock has a market cap of $77.40 billion, a price-to-earnings ratio of 27.09 and a beta of 1.13. Dow Chemical Company has a 12-month low of $51.57 and a 12-month high of $67.50.

Dow Chemical Company (The) (NYSE:DOW) last released its earnings results on Thursday, July 27th. The basic materials company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.01 by $0.07. Dow Chemical Company (The) had a net margin of 5.83% and a return on equity of 17.08%. The business had revenue of $13.83 billion for the quarter, compared to analysts’ expectations of $13.60 billion. During the same period last year, the company earned $0.95 earnings per share. The company’s quarterly revenue was up 15.7% on a year-over-year basis. On average, equities analysts expect that Dow Chemical Company will post $4.08 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Monday, July 31st will be given a $0.46 dividend. The ex-dividend date of this dividend is Thursday, July 27th. This represents a $1.84 annualized dividend and a dividend yield of 2.91%. Dow Chemical Company (The)’s dividend payout ratio is presently 76.99%.

COPYRIGHT VIOLATION WARNING: “Dow Chemical Company (The) (NYSE:DOW) Position Cut by Armstrong Shaw Associates Inc. CT” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://theolympiareport.com/2017/08/12/armstrong-shaw-associates-inc-ct-sells-105211-shares-of-dow-chemical-company-the-nysedow-updated.html.

DOW has been the topic of several recent analyst reports. Citigroup Inc. reiterated a “hold” rating and issued a $35.00 target price (down from $69.00) on shares of Dow Chemical Company (The) in a report on Friday, April 14th. Zacks Investment Research upgraded shares of Dow Chemical Company (The) from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a report on Tuesday, April 18th. Erste Group initiated coverage on shares of Dow Chemical Company (The) in a report on Tuesday, April 25th. They issued a “hold” rating on the stock. Royal Bank Of Canada reiterated a “buy” rating and issued a $76.00 target price on shares of Dow Chemical Company (The) in a report on Friday, April 28th. Finally, Barclays PLC boosted their target price on shares of Dow Chemical Company (The) from $65.00 to $67.00 and gave the company an “equal weight” rating in a report on Monday, May 1st. Two research analysts have rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $71.42.

Dow Chemical Company (The) Company Profile

Institutional Ownership by Quarter for Dow Chemical Company (The) (NYSE:DOW)

Receive News & Ratings for Dow Chemical Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.